Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19

被引：3
|
作者：
Gautret, Philippe [1 ,2 ]
Lagier, Jean-Christophe [1 ,2 ]
Honore, Stephane [3 ,4 ]
Van Thuan Hoang [1 ,2 ,5 ]
Raoult, Didier [1 ,6 ]
机构：
[1] IHU Mediterranee Infect, Marseille, France
[2] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France
[3] AP HM, Hop Timone, Serv Pharm, Marseille, France
[4] Aix Marseille Univ, Lab Pharmacie Clin, Marseille, France
[5] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam
[6] Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 57卷 / 01期
关键词：
D O I：
10.1016/j.ijantimicag.2020.106242
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
    Gautret, Philippe
    Honore, Stephane
    Lagier, Jean-Christophe
    Raoult, Didier
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [2] Hydroxychloroquine with or without Azithromycin in Covid-19
    Choudhary, Rahul
    Bohra, Gopal K.
    Kumar, Deepak
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 190 - 191
  • [3] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Alice Fanin
    Jessica Calegari
    Anna Beverina
    Silvia Tiraboschi
    Internal and Emergency Medicine, 2020, 15 : 841 - 843
  • [4] Hydroxychloroquine and azithromycin as a treatment of COVID-19
    Fanin, Alice
    Calegari, Jessica
    Beverina, Anna
    Tiraboschi, Silvia
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (05) : 841 - 843
  • [5] Hydroxychloroquine and Azithromycin as Treatments for COVID-19
    Ohe, Masashi
    Furuya, Ken
    Goudarzi, Houman
    GAZI MEDICAL JOURNAL, 2020, 31 (2A): : 337 - 338
  • [6] Cardiovascular Safety of Hydroxychloroquine-Azithromycin in 424 COVID-19 Patients
    Million, Matthieu
    Lagier, Jean-Christophe
    Hourdain, Jerome
    Franceschi, Frederic
    Deharo, Jean-Claude
    Parola, Philippe
    Brouqui, Philippe
    MEDICINA-LITHUANIA, 2023, 59 (05):
  • [7] Hydroxychloroquine: A review of its safety and efficacy in COVID-19
    Karia, Rutu H.
    Nagraj, Sanjana
    Gupta, Ishita
    Barua, Amit
    Kaur, Nirmaljot
    Singh, Harmandeep
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (03) : 1124 - 1133
  • [8] Hydroxychloroquine with or without Azithromycin in Covid-19 REPLY
    Cavalcanti, Alexandre B.
    Berwanger, Otavio
    Zampieri, Fernando G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 191 - 191
  • [9] Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
    Abou Warda, Ahmed E.
    Tammam, Mahmoud
    El-Gazar, Rabab A.
    Sarhan, Rania M.
    Gaber, Sayed
    CURRENT DRUG SAFETY, 2022, 17 (02) : 143 - 151
  • [10] Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence
    Bigna, Jean Joel
    Kamtchum-Tatuene, Joseph
    Noubiap, Jean Jacques
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 38
12345